Brief: Virios Therapeutics And Wex Pharmaceuticals Announce Business Combination To Form Dogwood Therapeutics

Dogwood Therapeutics

07/10/2024 12:12

Oct 7 (Reuters) - Virios Therapeutics Inc  VIRI.O :
    * VIRIOS THERAPEUTICS, INC. AND WEX PHARMACEUTICALS, INC.
ANNOUNCE
BUSINESS COMBINATION TO FORM DOGWOOD THERAPEUTICS, INC. (NASDAQ:
“DWTX”)
    * VIRIOS THERAPEUTICS INC - COMPANY ANNOUNCES 25-FOR-1
REVERSE
STOCK SPLIT EFFECTIVE OCT 9, 2024
    * VIRIOS THERAPEUTICS INC - COMBINED COMPANY TO BE NAMED
DOGWOOD
THERAPEUTICS, INC. (NASDAQ: DWTX)
    * VIRIOS THERAPEUTICS INC: ENTERED INTO DEFINITIVE SHARE
EXCHANGE
AGREEMENT WITH SEALBOND LIMITED, INDIRECT PARENT OF WEX
    * VIRIOS THERAPEUTICS- STRATEGIC FINANCING BY AFFILIATE OF
CK LIFE
SCIENCES INTEREST’L. RESULTS IN $23 MILLION WORKING CAPITAL
    * VIRIOS THERAPEUTICS: SEALBOND TO GET 211,383 SHARES OF
COMMON
STOCK & 2,108.3854 SHARES OF PREFERRED STOCK
    * VIRIOS THERAPEUTICS INC - DOGWOOD TO BE LED BY CEO GREG
DUNCAN
AND CMO MIKE GENDREAU

Source text for Eikon:  ID:nGNXc8xdZv 
Further company coverage:  VIRI.O 

 ((Reuters.Briefs@thomsonreuters.com;))